top of page
  • Lloyd Price

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?



Exec Summary:


To win the hearts and minds of the public in England and successfully deliver the NHS Federated Data Platform (FDP), Palantir should focus on the following strategies:

  1. Address Privacy Concerns: Public trust is paramount, particularly when dealing with sensitive patient data. Palantir should transparently explain its data handling practices, emphasizing robust security measures and adherence to strict privacy regulations.

  2. Engage with Stakeholders: Actively engage with NHS staff, patients, and advocacy groups to understand their concerns and address them proactively. Open communication and collaboration will foster trust and support.

  3. Demonstrate Benefits: Clearly articulate the tangible benefits of the FDP, highlighting how it will improve patient care, enhance research, and optimize resource allocation. Real-world examples and case studies can showcase the platform's impact.

  4. Emphasize Local Partnerships: Partner with local companies and organizations to demonstrate Palantir's commitment to the UK healthcare ecosystem. This local engagement will foster a sense of ownership and collaboration.

  5. Invest in Skills Development: Support the development of data literacy and analytics skills among NHS staff, enabling them to effectively utilize the FDP and maximize its benefits.

  6. Prioritize Data Security: Continuously invest in cutting-edge security measures to protect patient data and ensure compliance with the highest data protection standards. Transparency and accountability in data handling are crucial.

  7. Foster Open Dialogue: Encourage open dialogue and feedback from stakeholders throughout the FDP implementation process. Proactive engagement with concerns and suggestions will demonstrate Palantir's responsiveness and commitment to public trust.

  8. Showcase Success Stories: Share success stories and case studies that highlight how the FDP has improved patient outcomes and enhanced healthcare decision-making. Positive examples will build confidence in the platform's value.

  9. Educate the Public: Provide accessible and understandable educational materials about the FDP, explaining its purpose, benefits, and data security measures. Public understanding will foster trust and acceptance.

  10. Collaborate with Experts: Collaborate with healthcare experts and data specialists to continuously refine the FDP and ensure it meets the evolving needs of the NHS.

By implementing these strategies, Palantir can effectively address public concerns, build trust, and gain acceptance for its role in delivering the NHS Federated Data Platform, ultimately contributing to improved patient care and healthcare outcomes in England.


Corporate Development for Healthcare Technology companies in EMEA


Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://www.healthcare.digital


HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk


HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb


HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk



Intro to Palantir


Palantir Technologies is a software company that specializes in big data analytics. The company has a number of products that are designed to help organizations make better decisions based on data. Palantir's products are used by a variety of industries, including healthcare.


Palantir's plans for healthcare include using its products to help organizations improve patient care, reduce costs, and improve efficiency. The company's products can be used to:


  • Improve patient care: Palantir's products can be used to help organizations better understand patient data. This information can be used to improve diagnosis, treatment, and care coordination.

  • Reduce costs: Palantir's products can be used to help organizations identify areas where costs can be reduced. This can be done by identifying inefficiencies, waste, and fraud.

  • Improve efficiency: Palantir's products can be used to help organizations improve the efficiency of their operations. This can be done by automating tasks, improving communication, and streamlining processes.

Palantir's products are already being used by a number of healthcare organizations. The company has partnerships with organizations such as the Mayo Clinic, the University of California, San Francisco, and the Veterans Health Administration. Palantir's products are also being used by pharmaceutical companies, medical device manufacturers, and healthcare payers.


Palantir's plans for healthcare are ambitious. The company believes that its products can help to transform the healthcare industry. Palantir is already making a difference in the healthcare industry, and its products are likely to have a significant impact on the way healthcare is delivered in the years to come.



Palantir and Healthcare - what could the future hold?


The future is likely to be built on a previous track record of success which has included:

  • Palantir's software is able to integrate and analyze data from a variety of sources. This allows clinicians to have a more complete picture of a patient's health, which can help them to make better decisions about treatment.

  • Palantir's software is able to identify patterns and trends in data. This allows clinicians to see what is working and what is not, and to make changes to their treatment plans accordingly.

  • Palantir's software is able to make predictions about future events. This allows clinicians to be proactive in their treatment, and to prevent problems before they occur.

Overall, Palantir's software is helping to improve patient care, accelerate research, and improve drug development. The company is well-positioned to continue to be successful in healthcare in the future.


What are a few likely scenarios for Palantir in Healthcare? Buy, build or partner?


a) Buy: acquisition of a HealthTech company?


Acquisitions are likely; buying a Healthtech company provides quick access to the market, deep data sets, enables growth on existing data protection and information governance frameworks.


Some of the reasons why Palantir might buy a healthcare company:

  • To expand its reach in the healthcare industry. Palantir is currently focused on working with large healthcare organizations, such as the NHS and the US Department of Veterans Affairs. However, there are many smaller healthcare companies that could benefit from Palantir's software. By acquiring a healthcare company, Palantir could expand its reach and help more people.

  • To gain access to new technologies. Palantir is constantly developing new technologies, but it can also benefit from acquiring technologies that are already developed. By acquiring a healthcare company, Palantir could gain access to new technologies that could help it to improve its software and services.

  • To accelerate its growth. Palantir is growing rapidly, but it could accelerate its growth by acquiring a healthcare company. This would allow Palantir to add new customers, employees, and technologies to its business.

Of course, there are also some risks associated with Palantir buying a healthcare company. For example, the acquisition could be expensive, and it could take time for Palantir to integrate the acquired company into its business. However, the potential benefits of an acquisition could outweigh the risks.


Overall, it is possible that Palantir will buy a healthcare company in the future. The company has the resources and the motivation to make a major acquisition, and the healthcare industry is ripe for disruption.


b) Build: develop new products for the 4P's? Payers, providers, pharma and patients?


Palantir is building a number of products for healthcare, including:

  • Palantir Foundry: Foundry is a data analytics platform that can be used to integrate and analyze data from a variety of sources, including electronic health records (EHRs), medical devices, and research studies. Foundry can be used to identify patterns and trends in data, and to make predictions about future events.

  • Palantir Gotham: Gotham is a security platform that can be used to protect data and systems from cyberattacks. Gotham can be used to identify and respond to threats, and to prevent data breaches.

  • Palantir Apollo: Apollo is a platform that can be used to manage complex projects. Apollo can be used to track progress, identify risks, and make decisions.

Palantir's products are being used by a number of healthcare organizations, including the NHS, the US Department of Veterans Affairs, and Pfizer. Palantir's products are helping these organizations to improve patient care, accelerate research, and improve drug development.


Palantir is also working on a number of new products for healthcare, including:

  • Palantir Health Sciences: Health Sciences is a platform that can be used to improve the efficiency of drug discovery and development. Health Sciences can be used to manage clinical trials, track data, and make decisions.

  • Palantir Clinical Trial Harmonization: Clinical Trial Harmonization is a platform that can be used to standardize clinical trials. This can help to improve the efficiency and accuracy of clinical trials.

  • Palantir Cell Line Development: Cell Line Development is a platform that can be used to develop and characterize cell lines. This can help to improve the efficiency of drug discovery and development.

Palantir's products have the potential to revolutionize healthcare. By providing clinicians with access to more data and insights, Palantir can help improve patient care, accelerate research, and improve drug development.


c) Partner: strategic partnership with a HealthTech company?


The most likely scenario is Palantir continues to invest in strategic partnerships across different healthcare specialties, geographies and industries.


For example Palantir already has a number of strategic partnerships in healthcare, including:

  • Pfizer: Palantir is working with Pfizer to accelerate the development of new drugs. Palantir's software is being used to manage the complex process of drug development, from research and development to clinical trials and regulatory approval.

  • The US Department of Veterans Affairs: Palantir is working with the US Department of Veterans Affairs to improve the quality of care for veterans. Palantir's software is being used to analyze patient data to identify patterns and trends that can help clinicians improve care.

  • Cerner: Palantir is working with Cerner to improve the efficiency of healthcare operations. Palantir's software is being used to integrate and analyze data from a variety of sources, which can help clinicians make better decisions about treatment.

  • Dell Technologies: Palantir is working with Dell Technologies to provide healthcare organizations with a secure and scalable platform for data analytics. Dell Technologies' infrastructure can help Palantir's software to run more efficiently and securely.

These are just a few of Palantir's strategic partnerships in healthcare. As the company continues to develop its software, it is likely that Palantir will form even more partnerships with healthcare organizations.


These partnerships will help Palantir to bring its software to more people and to improve patient care, accelerate research, and improve drug development.


Corporate Development for Healthcare Technology companies in EMEA


Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://www.healthcare.digital


HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk


HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb


HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk






106 views
Screenshot 2023-11-06 at 13.13.55.png
bottom of page